secwatch.observer — SEC 8-K summary
======================================

Issuer:     Perspective Therapeutics, Inc. (CATX)
CIK:        0000728387
Form:       8-K
Filed at:   2023-05-15T23:59:59+00:00
Accession:  0001437749-23-014648
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Perspective Therapeutics appoints Heidi Henson to board as Audit Committee Chair; McCormick resigns
--------------------------------------------------------------------------------

- Michael McCormick resigned from the Board effective immediately; departure described as amicable.
- Heidi Henson appointed as director effective June 1, 2023, to fill the vacancy; named Audit Committee Chair.
- Rob Williamson steps down as Audit Committee Chair but remains a member; becomes Compensation Committee Chair.
- Lori Woods steps down as Compensation Committee Chair but remains a member.
- Henson has over 25 years of finance experience, most recently CFO of Pardes Biosciences.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/728387/000143774923014648/0001437749-23-014648-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/728387/000143774923014648/isr20230512_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-014648

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer